Multi-site comparison of factors influencing progress of African insecticide testing facilities towards an international Quality Management System certification.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
24
03
2021
accepted:
27
10
2021
entrez:
15
11
2021
pubmed:
16
11
2021
medline:
30
12
2021
Statut:
epublish
Résumé
Insecticidal mosquito vector control products are vital components of malaria control programmes. Test facilities are key in assessing the effectiveness of vector control products against local mosquito populations, in environments where they will be used. Data from these test facilities must be of a high quality to be accepted by regulatory authorities, including the WHO Prequalification Team for vector control products. In 2013-4, seven insecticide testing facilities across sub-Saharan Africa, with technical and financial support from Innovative Vector Control Consortium (IVCC), began development and implementation of quality management system compliant with the principles of Good Laboratory Practice (GLP) to improve data quality and reliability. We conducted semi-structured interviews, emails, and video-call interviews with individuals at five test facilities engaged in the IVCC-supported programme and working towards or having achieved GLP. We used framework analysis to identify and describe factors affeting progress towards GLP. We found that eight factors were instrumental in progress, and that test facilities had varying levels of control over these factors. They had high control over the training programme, project planning, and senior leadership support; medium control over infrastructure development, staff structure, and procurement; and low control over funding the availability and accessibility of relevant expertise. Collaboration with IVCC and other partners was key to overcoming the challenges associated with low and medium control factors. For partnership and consortia models of research capacity strengthening, test facilities can use their own internal resources to address identified high-control factors. Project plans should allow additional time for interaction with external agencies to address medium-control factors, and partners with access to expertise and funding should concentrate their efforts on supporting institutions to address low-control factors. In practice, this includes planning for financial sustainability at the outset, and acting to strengthen national and regional training capacity.
Sections du résumé
BACKGROUND
Insecticidal mosquito vector control products are vital components of malaria control programmes. Test facilities are key in assessing the effectiveness of vector control products against local mosquito populations, in environments where they will be used. Data from these test facilities must be of a high quality to be accepted by regulatory authorities, including the WHO Prequalification Team for vector control products. In 2013-4, seven insecticide testing facilities across sub-Saharan Africa, with technical and financial support from Innovative Vector Control Consortium (IVCC), began development and implementation of quality management system compliant with the principles of Good Laboratory Practice (GLP) to improve data quality and reliability.
METHODS AND PRINCIPLE FINDINGS
We conducted semi-structured interviews, emails, and video-call interviews with individuals at five test facilities engaged in the IVCC-supported programme and working towards or having achieved GLP. We used framework analysis to identify and describe factors affeting progress towards GLP. We found that eight factors were instrumental in progress, and that test facilities had varying levels of control over these factors. They had high control over the training programme, project planning, and senior leadership support; medium control over infrastructure development, staff structure, and procurement; and low control over funding the availability and accessibility of relevant expertise. Collaboration with IVCC and other partners was key to overcoming the challenges associated with low and medium control factors.
CONCLUSION
For partnership and consortia models of research capacity strengthening, test facilities can use their own internal resources to address identified high-control factors. Project plans should allow additional time for interaction with external agencies to address medium-control factors, and partners with access to expertise and funding should concentrate their efforts on supporting institutions to address low-control factors. In practice, this includes planning for financial sustainability at the outset, and acting to strengthen national and regional training capacity.
Identifiants
pubmed: 34780512
doi: 10.1371/journal.pone.0259849
pii: PONE-D-21-09716
pmc: PMC8592480
doi:
Substances chimiques
Insecticides
0
Types de publication
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0259849Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Am J Clin Pathol. 2015 Apr;143(4):566-72
pubmed: 25780009
Afr J Lab Med. 2014 Nov 03;3(2):222
pubmed: 29043193
J Infect Dev Ctries. 2013 Sep 16;7(9):676-9
pubmed: 24042104
Hum Reprod. 2010 Apr;25(4):1051-65
pubmed: 20097923
Glob Public Health. 2012;7(6):648-60
pubmed: 22519703
Int J Tuberc Lung Dis. 2010 Jan;14(1):59-64
pubmed: 20003696
Am J Clin Pathol. 2010 Sep;134(3):374-80
pubmed: 20716792
Afr J Lab Med. 2012 Oct 29;1(1):18
pubmed: 29062734
J Public Health Policy. 2012 Feb;33(1):34-45
pubmed: 22071568
Adm Policy Ment Health. 2015 Sep;42(5):533-44
pubmed: 24193818
Gates Open Res. 2020 Jun 12;4:59
pubmed: 32789289
Nurse Res. 2006 Jul 1;13(4):84
pubmed: 27702218
Am J Clin Pathol. 2010 Sep;134(3):393-400
pubmed: 20716795
Afr J Lab Med. 2014;3(2):216
pubmed: 26753130
Health Serv Res. 1999 Dec;34(5 Pt 2):1101-18
pubmed: 10591275
Coll Antropol. 2010 Mar;34(1):181-6
pubmed: 20437640
Am J Clin Pathol. 2010 Sep;134(3):410-8
pubmed: 20716797
Am J Clin Pathol. 2014 Feb;141(2):188-95
pubmed: 24436265
BMC Med Res Methodol. 2013 Sep 18;13:117
pubmed: 24047204
PLoS Negl Trop Dis. 2011 Oct;5(10):e1351
pubmed: 22022630
Trends Parasitol. 2016 Mar;32(3):187-196
pubmed: 26826784
J Gen Intern Med. 2013 Sep;28 Suppl 3:S654-9
pubmed: 23797915
Afr J Lab Med. 2014;3(3):
pubmed: 26752335
Trop Med Int Health. 2014 Apr;19(4):450-8
pubmed: 24506521
Am J Trop Med Hyg. 2012 Apr;86(4):573-9
pubmed: 22492138
Health Res Policy Syst. 2008 Aug 01;6:8
pubmed: 18673541
PLoS Negl Trop Dis. 2014 Mar 06;8(3):e2736
pubmed: 24603407
Clin Microbiol Infect. 2017 Jul;23(7):426-433
pubmed: 28506781
Am J Clin Pathol. 2010 Sep;134(3):401-9
pubmed: 20716796